Lin-Chi Chen, M.D. Ph.D., is a Scientific Associate Vice President at Merck, where they lead initiatives in early drug development. Previously, Chen served as a Senior Principal Scientist at Roche and Merck, focusing on translational medicine and clinical strategies for early oncology drug development. With experience as an Assistant Member at Nevada Cancer Institute, Chen established and directed clinical teams for various cancer types, and held positions at Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Institute during their medical training. Chen's extensive background in small molecules and biologic compounds, paired with academic and clinical expertise, underscores their role as an effective leader in the field.
This person is not in any teams
This person is not in any offices